Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Haas

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Biomedicines|October 28, 2023
Immunohistochemical Assessment of Microvessel Density in OSCC: Spatial Heterogeneity of Angiogenesis and Its Impact on SurvivalAndreas Mamilos, Alexander Lein, Lina Winter, et al.
Investigational New Drugs|November 7, 2023
The ATR inhibitor berzosertib acts as a radio- and chemosensitizer in head and neck squamous cell carcinoma cell linesJulia Schnoell, Carmen Sparr, Sega Al-Gboore, et al.
Investigational New Drugs|August 21, 2023
Early on-treatment C-reactive protein and its kinetics predict survival and response in recurrent and/or metastatic head and neck cancer patients receiving first-line pembrolizumabMarkus Haas, Alexander Lein, Thorsten Fuereder, et al.
Biomolecules & Biomedicine|August 28, 2023
Impact of the COVID-19 pandemic on management of surgically treated laryngeal squamous cell carcinomaAlexander Lein, David T Liu, Markus Haas, et al.
Nutrients|February 25, 2023
The Geriatric Nutritional Risk Index (GNRI) as a Prognostic Biomarker for Immune Checkpoint Inhibitor Response in Recurrent and/or Metastatic Head and Neck CancerMarkus Haas, Alexander Lein, Thorsten Fuereder, et al.
Acta Otorhinolaryngologica Italica : Organo Ufficiale Della Societa Italiana Di Otorinolaringologia E Chirurgia Cervico-Facciale|May 7, 2024
Changes in management of head and neck malignancies during the COVID-19 pandemicAlexander Lein, Fuad Brkic, David T Liu, et al.
Oral Diseases|May 8, 2023
Targeting TGF beta receptor 1 in head and neck squamous cell carcinomaBernhard J Jank, Julia Schnoell, Katharina Kladnik, et al.
International Immunopharmacology|August 20, 2023
Low free triiodothyronine and immune-related hyperthyroidism are associated with overall and progression-free survival in head and neck squamous cell carcinoma treated with pembrolizumabMarkus Haas, Alexander Lein, Thorsten Fuereder, et al.
Seminars in Thrombosis and Hemostasis|September 30, 2009
Improving antithrombotic management in patients with atrial fibrillation: current status and perspectivesMarcel Levi, F D Richard Hobbs, Alan K Jacobson, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Biomedicines|October 28, 2023
Immunohistochemical Assessment of Microvessel Density in OSCC: Spatial Heterogeneity of Angiogenesis and Its Impact on SurvivalAndreas Mamilos, Alexander Lein, Lina Winter, et al.
Investigational New Drugs|November 7, 2023
The ATR inhibitor berzosertib acts as a radio- and chemosensitizer in head and neck squamous cell carcinoma cell linesJulia Schnoell, Carmen Sparr, Sega Al-Gboore, et al.
Investigational New Drugs|August 21, 2023
Early on-treatment C-reactive protein and its kinetics predict survival and response in recurrent and/or metastatic head and neck cancer patients receiving first-line pembrolizumabMarkus Haas, Alexander Lein, Thorsten Fuereder, et al.
Biomolecules & Biomedicine|August 28, 2023
Impact of the COVID-19 pandemic on management of surgically treated laryngeal squamous cell carcinomaAlexander Lein, David T Liu, Markus Haas, et al.
Nutrients|February 25, 2023
The Geriatric Nutritional Risk Index (GNRI) as a Prognostic Biomarker for Immune Checkpoint Inhibitor Response in Recurrent and/or Metastatic Head and Neck CancerMarkus Haas, Alexander Lein, Thorsten Fuereder, et al.
Acta Otorhinolaryngologica Italica : Organo Ufficiale Della Societa Italiana Di Otorinolaringologia E Chirurgia Cervico-Facciale|May 7, 2024
Changes in management of head and neck malignancies during the COVID-19 pandemicAlexander Lein, Fuad Brkic, David T Liu, et al.
Oral Diseases|May 8, 2023
Targeting TGF beta receptor 1 in head and neck squamous cell carcinomaBernhard J Jank, Julia Schnoell, Katharina Kladnik, et al.
International Immunopharmacology|August 20, 2023
Low free triiodothyronine and immune-related hyperthyroidism are associated with overall and progression-free survival in head and neck squamous cell carcinoma treated with pembrolizumabMarkus Haas, Alexander Lein, Thorsten Fuereder, et al.
Seminars in Thrombosis and Hemostasis|September 30, 2009
Improving antithrombotic management in patients with atrial fibrillation: current status and perspectivesMarcel Levi, F D Richard Hobbs, Alan K Jacobson, et al.
Pageof 3